论文部分内容阅读
自从国内报道“人胎肝细胞悬液”(FLC)治疗重型肝炎获得疗效以来,引起了肝病研究者的重视并为众多的患者所关注。但临床广泛应用FLC尚存在两个亟待解决的问题:(1)
Since the domestic report of “human fetal liver cell suspension” (FLC) for the treatment of severe hepatitis has caused the attention of liver disease researchers and for many patients attention. However, there are still two urgent problems to be solved in clinical application of FLC: (1)